论文部分内容阅读
Elevated homocysteine is associated with increased risk of heart disease,stroke,and dementia.Therapy of Parkinson disease(PD)with levodopa elevates homocysteine.The authors conducted a 6-week,multicenter,randomized,double-blind,placebo-controlled trial to test whether folate 1 mg/vitamin B12 500 μg or entacapone reduced serum homocysteine in 35 levodopa-treated PD patients.Levodopa initiation caused a small elevation in homocysteine.Vitamin therapy,but not entacapone,resulted in a decrease in homocysteine compared to placebo.
Elevated homocysteine is associated with increased risk of heart disease, stroke, and dementia. Therapy of Parkinson disease (PD) with levodopa elevates homocysteine. The authors conducted a 6-week, multicenter, randomized, double-blind, placebo-controlled trial to test Whether folate 1 mg / vitamin B12 500 μg or entacapone reduced serum homocysteine in 35 levodopa-treated PD patients. Levodopa initiation caused a small elevation in homocysteine. Vitamin therapy, but not entacapone, resulted in a decrease in homocysteine compared to placebo.